Intra Cellular Therapies | ITCI - Capitalización De Mercado



Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
ALKERMES USD 4.62B 333M 2025-12
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cytokinetics USD 7.77B 1.19B 2025-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
J&J USD 500.24B 67.44B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 263.08B 17.01B 2025-12
Prothena USD 514M 11M 2025-12
RedHill Biopharma USD 12M 17M 2024-06
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12